pharmaphorum

OCTOBER 12, 2022

The 2023 Transdermal and Microneedle Drug Delivery Conference will explore real world applications of microneedles in drug delivery and strategies for advanced and user-centric device design. Regulation of transdermal delivery systems will be another key theme addressed, in combination with clinical trial optimization.

Drug Delivery 40

Drug Delivery Drugs Packaging Packaging 40

The Pharma Data

NOVEMBER 2, 2020

. “Psychedelic agents are a promising new class of therapeutic drug. We see a natural opportunity to apply XPhyto’s drug formulation expertise and Vektor’s proven drug delivery platforms to these emerging APIs,” said Hugh Rogers, CEO and Director of XPhyto. About XPhyto Therapeutics Corp.

Production 52

Production Development Drug Delivery Drugs 52

The Pharma Data

OCTOBER 27, 2020

Pharmaceutical-Grade Hand Sanitizer Available for Sale Across Canada. For bulk / commercial sales of DermSafe please contact one of our Canadian distributors or email us directly at info@ovationscience.com. According to Statista.com in late 2019, e-commerce retail trade sales amounted to almost 1.85 Ovation Science Inc.

Sales 52

Sales Production Drug Delivery Development 52

The Pharma Data

OCTOBER 27, 2020

On April 20, 2020, XPhyto announced a definitive development, technology purchase and licence agreement with 3a-Diagnostics for the development and commercialization of real-time, low-cost and easy-to-use screening tests using 3a’s pathogen specific biosensors and XPhyto’s oral dissolvable drug delivery platform.

RNA 52

RNA Drug Delivery Production In-Vitro 52

XTalks

OCTOBER 27, 2021

Genentech’s ocular implant drug delivery system for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port delivery system into a surgically placed implant in the eye, allowing for continuous delivery of the drug.

Drug Delivery Systems 104

Drug Delivery Systems Drug Delivery FDA Approval Drugs 104

The Pharma Data

NOVEMBER 9, 2020

is accelerating the next-generation drug delivery, diagnostic, and phytochemical investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and validation of approved cannabinoid-based therapeutics focused on European markets.

Development 40

Development Drugs Drug Delivery Production 40

The Pharma Data

NOVEMBER 4, 2020

is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and phyto-therapeutic investment opportunities: precision transdermal and oral dissolvable drug dosage forms; rapid, low-cost infectious disease and oral health screening tools; and emerging plant-based therapeutics focused on European markets.

Drug Delivery 40

Drug Delivery Production Manufacturing Life Science 40